Self-Administered Etripamil and Emergency Department Visits in Supraventricular Tachycardia
This secondary analysis of a randomized clinical trial describes the use of emergency care after self-administration of etripamil by patients experiencing paroxysmal supraventricular tachycardia episodes at home.
Authors
- Sean D. Pokorney (ORCID: https://orcid.org/0000-0002-4345-0816)
- Jonathan Paul Piccini (ORCID: https://orcid.org/0000-0003-0772-2404)
- Paul Dorian
- James E. Ip (ORCID: https://orcid.org/0000-0002-3461-505X)
- Bruce S. Stambler (ORCID: https://orcid.org/0000-0001-5692-2619)
- A. John Camm
- David B. Bharucha
Institutions
- NewYork–Presbyterian Hospital (US)
- St George's, University of London (GB)
- Duke University (US)
- Cornell University (US)
- New York Hospital Queens (US)
- Presbyterian Hospital (US)
- Piedmont HealthCare (US)
- Weill Cornell Medicine (US)
- Unity Health Toronto
Publication Details
- Journal
- JAMA Cardiology
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1001/jamacardio.2025.0417
- Citations
- 2
- Primary Topic
- Cardiac Arrhythmias and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- Bristol-Myers Squibb
- Pfizer
- GlaxoSmithKline
- Sanofi
- Boston Scientific Corporation
- Daiichi-Sankyo